본문 바로가기
KERD
논문KCI 등재

Inflammatory Biomarkers and Bipolar Disorder: Neutrophil/Lymphocyte Ratio, Monocyte/Lymphocyte Ratio and Platelet/Lymphocyte Ratio

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objectives:Neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR) are indicators of inflammation. Several studies have evaluated their relationship with bipolar disorder severity, but the results are controversial. Here, we investigate the relationship between inflammatory ratios and the severity and clinical characteristics of bipolar disorder. Methods:We retrospectively reviewed the medical records of bipolar disorder patients who met the inclusion criteria and admitted to Kosin University Gospel Hospital between January 2010 and August 2021. NLR, MLR and PLR were measured according to the complete blood count. Severity was assessed by the Young Mania Rating Scale (YMRS) in hypo/manic episode patients, the Hamilton Rating Scale for Depression (HAMD) in depressive episode patients. Patients are grouped by presence of two clinical features, current psychotic features and history of suicide attempts. Results:181 subjects, of whom 123 were women and 58 men, were included. Subjects with higher NLR had higher HAMD scores (N=36, r=0.337, p=0.045). We found no significant correlation between YMRS and the inflammatory biomarkers. Patients with previous suicide attempts exhibited a greater PLR than those without previous suicide attempts (N[SA+]=52, N[SA-]=129, p=0.035). There was no significant difference in inflammatory ratios with respect to psychotic features. Conclusions:We found a possible correlation between the severity of bipolar depression and inflammatory indicators in the Korean population, in addition to correlation between previous suicidal attempt of bipolar disorder and inflammatory indicators. A well-designed prospective study involving a larger cohort is needed in the future.

Abstract

Objectives:Neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR) are indicators of inflammation. Several studies have evaluated their relationship with bipolar disorder severity, but the results are controversial. Here, we investigate the relationship between inflammatory ratios and the severity and clinical characteristics of bipolar disorder. Methods:We retrospectively reviewed the medical records of bipolar disorder patients who met the inclusion criteria and admitted to Kosin University Gospel Hospital between January 2010 and August 2021. NLR, MLR and PLR were measured according to the complete blood count. Severity was assessed by the Young Mania Rating Scale (YMRS) in hypo/manic episode patients, the Hamilton Rating Scale for Depression (HAMD) in depressive episode patients. Patients are grouped by presence of two clinical features, current psychotic features and history of suicide attempts. Results:181 subjects, of whom 123 were women and 58 men, were included. Subjects with higher NLR had higher HAMD scores (N=36, r=0.337, p=0.045). We found no significant correlation between YMRS and the inflammatory biomarkers. Patients with previous suicide attempts exhibited a greater PLR than those without previous suicide attempts (N[SA+]=52, N[SA-]=129, p=0.035). There was no significant difference in inflammatory ratios with respect to psychotic features. Conclusions:We found a possible correlation between the severity of bipolar depression and inflammatory indicators in the Korean population, in addition to correlation between previous suicidal attempt of bipolar disorder and inflammatory indicators. A well-designed prospective study involving a larger cohort is needed in the future.

참고문헌 (45)

  1. Grande I, "Bipolar disorder", Lancet, 387, pp.1561~1572 (2016)
  2. Barbosa IG, "A preliminary report of increased plasma levels of IL-33 in bipolar disorder : further evidence of pro-inflammatory status", J Affect Disord, 157, pp.41~44 (2014)
  3. Clemente AS, "Bipolar disorder prevalence : a systematic review and meta-analysis of the literature", Braz J Psychiatry, 37, pp.155~161 (2015)
  4. Costa Lda S, "Risk factors for suicide in bipolar disorder : a systematic review", J Affect Disord, 170, pp.237~254 (2015)
  5. Kalelioglu T, "Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder", Psychiatry Res, 228, pp.925~927 (2015)
  6. Sayana P, "A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients", J Psychiatr Res, 92, pp.160~182 (2017)
  7. Drexhage RC, "The activation of monocyte and T cell networks in patients with bipolar disorder", Brain Behav Immun, 25, pp.1206~1213 (2011)
  8. Munkholm K, "Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis", J Psychiatr Res, 47, pp.1119~1133 (2013)
  9. Fernandes BS, "C-reactive protein concentrations across the mood spectrum in bipolar disorder : a systematic review and meta-analysis", Lancet Psychiatry, 3, pp.1147~1156 (2016)
  10. Mazza MG, "Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders", Gen Hosp Psychiatry, 58, pp.7~12 (2019)
  11. Liu J, "The correlation between PLR-NLR and prognosis in acute myocardial infarction", Am J Transl Res, 13, pp.4892~4899 (2021)
  12. Cheng HR, "High monocyte-to-lymphocyte ratio is associated with stroke-associated pneumonia", Front Neurol, 11, pp.575809~ (2020)
  13. Li M, "Correlation between NLR, PLR, and LMR and disease activity, efficacy assessment in rheumatoid arthritis", Evid Based Complement Alternat Med, 2021, pp.4433141~ (2021)
  14. Afari ME, "Neutrophil to lymphocyte ratio(NLR)and cardiovascular diseases : an update", Expert Rev Cardiovasc Ther, 14, pp.573~577 (2016)
  15. Min GT, "The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer : a systematic review and meta-analysis", Clin Transplant, 32 (2018)
  16. Yang Z, "Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases", Apmis, 125, pp.863~871 (2017)
  17. Yao C, "Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD", Int J Chron Obstruct Pulmon Dis, 12, pp.2285~2290 (2017)
  18. Semiz M, "Elevated neutrophil", lymphocyte ratio in patients with schizophrenia, 2014, pp.26, 220~225
  19. Özdin S, "Neutrophil", lymphocyte, platelet, lymphocyte ratios in different stages of schizophrenia, pp.Psychiatry Res, 2019[DOI]
  20. Kuyumcu ME, "The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease", Dement Geriatr Cogn Disord, 34, pp.69~74 (2012)
  21. Sayed A, "The neutrophil-to-lymphocyte ratio in Alzheimer’s disease : Current understanding and potential applications", J Neuroimmunol, 349, pp.577398~ (2020)
  22. Kayhan F, "Relationships of neutrophil-lymphocyte and platelet-lymphocyte ratios with the severity of major depression", Psychiatry Res, 247, pp.332~335 (2017)
  23. Esra Aydin Sunbul, "Increased Neutrophil", Lymphocyte Ratio in Patients with Depression is Correlated with the Severity of Depression and Cardiovascular Risk Factors, 2016, pp.13(1), 121~126[DOI]
  24. Özdin S, "A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients-a retrospective file review", Nord J Psychiatry, 71, pp.509~512 (2017)
  25. Inanli I, "Neutrophil", lymphocyte ratio, monocyte, Nord J Psychiatry, pp.2019, 73[DOI]
  26. Özdin S, "A comparison of inflammatory markers in manic and euthymic states of bipolar disorder", Nord J Psychiatry, 75, pp.124~129 (2021)
  27. Ivković M, "Neutrophil-to-lymphocyte ratio predicting suicide risk in euthymic patients with bipolar disorder : moderatory effect of family history", Compr Psychiatry, 66, pp.87~95 (2016)
  28. Beck A, "Classification and nomenclature, in suicide prevention in the seventies", Government Printing Office, ~ (1972)
  29. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
  30. Kraus C, "Administration of ketamine for unipolar and bipolar depression", Int J Psychiatry Clin Pract, 21, pp.2~12 (2017)
  31. Husain MI, "Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial", Lancet Psychiatry, 7, pp.515~527 (2020)
  32. Young RC, "A rating scale for mania: reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)
  33. Marazziti D, "Neutrophil", lymphocyte, platelet, lymphocyte ratios in mood disorders, pp.Curr Med Chem, 2022[DOI]
  34. Melo MCA, "Clinical significance of neutrophil-lymphocyte and platelet-lymphocyte ratios in bipolar patients : an 18-month prospective study", Psychiatry Res, 271, pp.8~14 (2019)
  35. Kolaczkowska E, "Neutrophil recruitment and function in health and inflammation", Nat Rev Immunol, 13, pp.159~175 (2013)
  36. Miná VAL, "The influence of inflammatory cytokines in physiopathology of suicidal behavior", J Affect Disord, 172, pp.219~230 (2015)
  37. Serafini G, "The role of inflammatory cytokines in suicidal behavior : a systematic review", Eur Neuropsychopharmacol, 23, pp.1672~1686 (2013)
  38. Maget A, "Differences in kynurenine metabolism during depressive, manic, and euthymic phases of bipolar affective disorder", Curr Top Med Chem, 20, pp.1344~1352 (2020)
  39. Lin PY, "State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder : a metaanalytic study", Neurosci Lett, 466, pp.139~143 (2009)
  40. Fernandes BS, "Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders : a systematic review and meta-regression analysis", J Psychiatr Res, 45, pp.995~1004 (2011)
  41. Solmi M, "Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability", Brain Behav Immun, 97, pp.193~203 (2021)
  42. Ohgidani M, "Microglial CD206 gene has potential as a state marker of bipolar disorder", Front Immunol, 7, pp.676~ (2017)
  43. Siwek M, "The serum concentration of magnesium as a potential state marker in patients with diagnosis of bipolar disorder", Psychiatr Pol, 49, pp.1277~1287 (2015)
  44. Rosenblat JD, "Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications", Brain Sci, 7, pp.144~ (2017)
  45. Gan Z, "The association between low-grade inflammation and the clinical features of bipolar disorder in Han Chinese population", Psychoneuroendocrinology, 101, pp.286~294 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (3건)